Momenta Pharmaceuticals Inc. (MNTA)
-NasdaqGS 14.12 
0.29(2.01%) 3:59PM EDT|After Hours
:
14.14 0.02 (0.14%) 4:15PM EDT - Nasdaq Real Time Price
| Prev Close: | 14.41 |
|---|
| Open: | 14.45 |
|---|
| Bid: | 13.12 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 15.83 |
|---|
| Beta: | 2.53 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 14.02 - 14.61 |
|---|
| 52wk Range: | 10.05 - 17.09 |
|---|
| Volume: | 262,573 |
|---|
| Avg Vol (3m): | 282,967 |
|---|
| Market Cap: | 716.18M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.54 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Coverage initiated on Momenta Pharma by WallachBethBriefing.com(Mon, Jun 17)
- White Collar Criminals Love Biotech Stocksat Motley Fool(Sun, Jun 16)
- Why the Pfizer-Teva Settlement Affects the Whole Industyat Motley Fool(Thu, Jun 13)
- MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial StatemEDGAR Online(Thu, Jun 13)
- Commit To Buy Momenta Pharmaceuticals At $11, Earn 15.7% Annualizedat Forbes(Mon, Jun 10)
- Movers roundup: Ascena Retail, MomentaAP(Thu, Jun 6)
- Momenta Pharma rises following upgrade from UBSAP(Thu, Jun 6)
- Stock Upgrades: Stick to Henkel Like Glueat Minyanville(Thu, Jun 6)
- Why Baxter Is Soaring Despite Alzheimer's Disappointmentat Motley Fool(Wed, May 29)
- Momenta Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript)at Seeking Alpha(Wed, May 29)
- The 5 Best Dividend Stocks of 2020at Motley Fool(Sun, May 26)
- Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor ConferencesGlobeNewswire(Thu, May 23)
- Momenta Pharmaceuticals Management Presents at 2013 UBS Global Healthcare Conference (Transcript)at Seeking Alpha(Wed, May 22)
- Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industryat Seeking Alpha(Wed, May 22)
- MOMENTA PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Fri, May 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 15.45 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.88 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.46 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Momenta Pharmaceuticals, Inc., a biotechnology company, engages in the structural characterization, process engineering, and biologic systems analysis of complex molecules.
View More